APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung Surfactants

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lung Surfactants Industry Growth and Trends Forecast to 2032

2 January 202691 pages

Choose your research edition.

Industry ResearchLung Surfactants Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Surfactants Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Lung Surfactants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Surfactants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Surfactants Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lung Surfactants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lung Surfactants include Aviva Systems Biology Corporation, Chiesi Farmaceutici, Lyomark Pharma, ONY Biotech, Windtree Therapeutics and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lung Surfactants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lung Surfactants market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lung Surfactants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lung Surfactants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lung Surfactants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lung Surfactants Market by Company

Aviva Systems Biology Corporation

Chiesi Farmaceutici

Lyomark Pharma

ONY Biotech

Windtree Therapeutics

AbbVie

Lung Surfactants Segment by Type

Intratracheal

Injectable

Lung Surfactants Segment by Application

Special Clinic

Hospital

Recovery Center

Lung Surfactants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Surfactants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Surfactants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Surfactants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lung Surfactants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lung Surfactants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intratracheal Table 2. Major Company of Injectable Table 3. Global Lung Surfactants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 5. Global Lung Surfactants Sales Market Share in Volume by Type (2021-2026) Table 6. Global Lung Surfactants Sales by Type (2021-2026) & (US$ Million) Table 7. Global Lung Surfactants Sales Market Share in Value by Type (2021-2026) Table 8. Global Lung Surfactants Price by Type (2021-2026) & (US$/Unit) Table 9. Global Lung Surfactants Sales by Type (2027-2032) & (K Units) Table 10. Global Lung Surfactants Sales Market Share in Volume by Type (2027-2032) Table 11. Global Lung Surfactants Sales by Type (2027-2032) & (US$ Million) Table 12. Global Lung Surfactants Sales Market Share in Value by Type (2027-2032) Table 13. Global Lung Surfactants Price by Type (2027-2032) & (US$/Unit) Table 14. North America Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 15. North America Lung Surfactants Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 17. Europe Lung Surfactants Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Lung Surfactants Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 21. Latin America Lung Surfactants Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Lung Surfactants Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Lung Surfactants Sales by Type (2021-2026) & (US$ Million) Table 24. Lung Surfactants Industry Trends Table 25. Lung Surfactants Industry Drivers Table 26. Lung Surfactants Industry Opportunities and Challenges Table 27. Lung Surfactants Industry Restraints Table 28. Global Lung Surfactants Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Lung Surfactants Revenue Market Share by Company (2021-2026) Table 30. Global Lung Surfactants Sales by Company (2021-2026) & (K Units) Table 31. Global Lung Surfactants Sales Share by Company (2021-2026) Table 32. Global Lung Surfactants Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Lung Surfactants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Lung Surfactants Major Company Production Sites and Headquarters Table 35. Global Lung Surfactants Company, Product Type & Application Table 36. Global Lung Surfactants Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Lung Surfactants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Lung Surfactants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Lung Surfactants Sales by Region (2021-2026) & (K Units) Table 41. Global Lung Surfactants Sales Market Share in Volume by Region (2021-2026) Table 42. Global Lung Surfactants Sales by Region (2021-2026) & (US$ Million) Table 43. Global Lung Surfactants Sales Market Share in Value by Region (2021-2026) Table 44. Global Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Lung Surfactants Sales by Region (2027-2032) & (K Units) Table 46. Global Lung Surfactants Sales Market Share in Volume by Region (2027-2032) Table 47. Global Lung Surfactants Sales by Region (2027-2032) & (US$ Million) Table 48. Global Lung Surfactants Sales Market Share in Value by Region (2027-2032) Table 49. Global Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Lung Surfactants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 52. Global Lung Surfactants Sales Market Share in Volume by Application (2021-2026) Table 53. Global Lung Surfactants Sales by Application (2021-2026) & (US$ Million) Table 54. Global Lung Surfactants Sales Market Share in Value by Application (2021-2026) Table 55. Global Lung Surfactants Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lung Surfactants Sales by Application (2027-2032) & (K Units) Table 57. Global Lung Surfactants Sales Market Share in Volume by Application (2027-2032) Table 58. Global Lung Surfactants Sales by Application (2027-2032) & (US$ Million) Table 59. Global Lung Surfactants Sales Market Share in Value by Application (2027-2032) Table 60. Global Lung Surfactants Price by Application (2027-2032) & (US$/Unit) Table 61. North America Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 62. North America Lung Surfactants Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 64. Europe Lung Surfactants Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Lung Surfactants Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 68. Latin America Lung Surfactants Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Lung Surfactants Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Lung Surfactants Sales by Application (2021-2026) & (US$ Million) Table 71. Aviva Systems Biology Corporation Company Information Table 72. Aviva Systems Biology Corporation Business Overview Table 73. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aviva Systems Biology Corporation Lung Surfactants Product Portfolio Table 75. Aviva Systems Biology Corporation Recent Development Table 76. Chiesi Farmaceutici Company Information Table 77. Chiesi Farmaceutici Business Overview Table 78. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Chiesi Farmaceutici Lung Surfactants Product Portfolio Table 80. Chiesi Farmaceutici Recent Development Table 81. Lyomark Pharma Company Information Table 82. Lyomark Pharma Business Overview Table 83. Lyomark Pharma Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Lyomark Pharma Lung Surfactants Product Portfolio Table 85. Lyomark Pharma Recent Development Table 86. ONY Biotech Company Information Table 87. ONY Biotech Business Overview Table 88. ONY Biotech Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. ONY Biotech Lung Surfactants Product Portfolio Table 90. ONY Biotech Recent Development Table 91. Windtree Therapeutics Company Information Table 92. Windtree Therapeutics Business Overview Table 93. Windtree Therapeutics Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Windtree Therapeutics Lung Surfactants Product Portfolio Table 95. Windtree Therapeutics Recent Development Table 96. AbbVie Company Information Table 97. AbbVie Business Overview Table 98. AbbVie Lung Surfactants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. AbbVie Lung Surfactants Product Portfolio Table 100. AbbVie Recent Development Table 101. North America Lung Surfactants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 103. North America Lung Surfactants Sales Market Share by Country (2021-2026) Table 104. North America Lung Surfactants Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Lung Surfactants Sales Market Share Forecast by Country (2027-2032) Table 106. North America Lung Surfactants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Lung Surfactants Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Lung Surfactants Market Share by Country (2021-2026) Table 109. North America Lung Surfactants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Lung Surfactants Market Share Forecast by Country (2027-2032) Table 111. Europe Lung Surfactants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 113. Europe Lung Surfactants Sales Market Share by Country (2021-2026) Table 114. Europe Lung Surfactants Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Lung Surfactants Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Lung Surfactants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Lung Surfactants Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Lung Surfactants Market Share by Country (2021-2026) Table 119. Europe Lung Surfactants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Lung Surfactants Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Lung Surfactants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Lung Surfactants Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Lung Surfactants Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Lung Surfactants Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Lung Surfactants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Lung Surfactants Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Lung Surfactants Market Share by Country (2021-2026) Table 129. Asia-Pacific Lung Surfactants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Lung Surfactants Market Share Forecast by Country (2027-2032) Table 131. Latin America Lung Surfactants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 133. Latin America Lung Surfactants Sales Market Share by Country (2021-2026) Table 134. Latin America Lung Surfactants Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Lung Surfactants Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Lung Surfactants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Lung Surfactants Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Lung Surfactants Market Share by Country (2021-2026) Table 139. Latin America Lung Surfactants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Lung Surfactants Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Lung Surfactants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Lung Surfactants Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Lung Surfactants Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Lung Surfactants Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Lung Surfactants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Lung Surfactants Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Lung Surfactants Market Share by Country (2021-2026) Table 149. Middle East and Africa Lung Surfactants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Lung Surfactants Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Lung Surfactants Distributors List Table 154. Lung Surfactants Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Lung Surfactants Image Figure 2. Global Lung Surfactants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung Surfactants Market Size (2021-2032) & (US$ Million) Figure 4. Global Lung Surfactants Sales (2021-2032) & (K Units) Figure 5. Intratracheal Image Figure 6. Global Intratracheal Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injectable Image Figure 8. Global Injectable Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Lung Surfactants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Lung Surfactants Market Share by Type 2025 VS 2032 Figure 11. North America Lung Surfactants Sales Market Share in Volume by Type in 2025 Figure 12. North America Lung Surfactants Sales Market Share in Value by Type in 2025 Figure 13. Europe Lung Surfactants Sales Market Share in Volume by Type in 2025 Figure 14. Europe Lung Surfactants Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Lung Surfactants Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Lung Surfactants Sales Market Share in Value by Type in 2025 Figure 17. Latin America Lung Surfactants Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Lung Surfactants Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Lung Surfactants Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Lung Surfactants Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Lung Surfactants Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Special Clinic Image Figure 24. Global Special Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Recovery Center Image Figure 28. Global Recovery Center Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Lung Surfactants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Lung Surfactants Market Share by Application 2025 VS 2032 Figure 31. North America Lung Surfactants Sales Market Share in Volume by Application in 2025 Figure 32. North America Lung Surfactants Sales Market Share in Value by Application in 2025 Figure 33. Europe Lung Surfactants Sales Market Share in Volume by Application in 2025 Figure 34. Europe Lung Surfactants Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Lung Surfactants Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Lung Surfactants Sales Market Share in Value by Application in 2025 Figure 37. Latin America Lung Surfactants Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Lung Surfactants Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Lung Surfactants Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Lung Surfactants Sales Market Share in Value by Application in 2025 Figure 41. North America Lung Surfactants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Lung Surfactants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Lung Surfactants Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lung Surfactants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Lung Surfactants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Lung Surfactants Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lung Surfactants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Lung Surfactants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Lung Surfactants Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lung Surfactants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Lung Surfactants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Lung Surfactants Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lung Surfactants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Lung Surfactants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Lung Surfactants Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Lung Surfactants Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Lung Surfactants Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intratracheal
  • Injectable
Applications
  • Special Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Aviva Systems Biology Corporation
  • Chiesi Farmaceutici
  • Lyomark Pharma
  • ONY Biotech
  • Windtree Therapeutics
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lung Surfactants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lung Surfactants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lung Surfactants Market by Type
  6. 1.3.1 Intratracheal
  7. 1.3.2 Injectable
  8. 1.4 Global Lung Surfactants Market Size by Type
  9. 1.4.1 Global Lung Surfactants Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Lung Surfactants Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Lung Surfactants Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Lung Surfactants Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Lung Surfactants Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Lung Surfactants Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Lung Surfactants Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Lung Surfactants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lung Surfactants Industry Trends
  2. 2.2 Lung Surfactants Industry Drivers
  3. 2.3 Lung Surfactants Industry Opportunities and Challenges
  4. 2.4 Lung Surfactants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lung Surfactants Revenue (2021-2026)
  2. 3.2 Global Top Players by Lung Surfactants Sales (2021-2026)
  3. 3.3 Global Top Players by Lung Surfactants Price (2021-2026)
  4. 3.4 Global Lung Surfactants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lung Surfactants Major Company Production Sites & Headquarters
  6. 3.6 Global Lung Surfactants Company, Product Type & Application
  7. 3.7 Global Lung Surfactants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lung Surfactants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lung Surfactants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lung Surfactants Tier 1, Tier 2, and Tier 3
4 Lung Surfactants Regional Status and Outlook
  1. 4.1 Global Lung Surfactants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lung Surfactants Historic Market Size by Region
  3. 4.2.1 Global Lung Surfactants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lung Surfactants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lung Surfactants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lung Surfactants Forecasted Market Size by Region
  7. 4.3.1 Global Lung Surfactants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lung Surfactants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lung Surfactants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lung Surfactants by Application
  1. 5.1 Lung Surfactants Market by Application
  2. 5.1.1 Special Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Lung Surfactants Market Size by Application
  6. 5.2.1 Global Lung Surfactants Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lung Surfactants Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lung Surfactants Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lung Surfactants Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lung Surfactants Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lung Surfactants Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lung Surfactants Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lung Surfactants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aviva Systems Biology Corporation
  2. 6.1.1 Aviva Systems Biology Corporation Company Information
  3. 6.1.2 Aviva Systems Biology Corporation Business Overview
  4. 6.1.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aviva Systems Biology Corporation Lung Surfactants Product Portfolio
  6. 6.1.5 Aviva Systems Biology Corporation Recent Developments
  7. 6.2 Chiesi Farmaceutici
  8. 6.2.1 Chiesi Farmaceutici Company Information
  9. 6.2.2 Chiesi Farmaceutici Business Overview
  10. 6.2.3 Chiesi Farmaceutici Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chiesi Farmaceutici Lung Surfactants Product Portfolio
  12. 6.2.5 Chiesi Farmaceutici Recent Developments
  13. 6.3 Lyomark Pharma
  14. 6.3.1 Lyomark Pharma Company Information
  15. 6.3.2 Lyomark Pharma Business Overview
  16. 6.3.3 Lyomark Pharma Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lyomark Pharma Lung Surfactants Product Portfolio
  18. 6.3.5 Lyomark Pharma Recent Developments
  19. 6.4 ONY Biotech
  20. 6.4.1 ONY Biotech Company Information
  21. 6.4.2 ONY Biotech Business Overview
  22. 6.4.3 ONY Biotech Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ONY Biotech Lung Surfactants Product Portfolio
  24. 6.4.5 ONY Biotech Recent Developments
  25. 6.5 Windtree Therapeutics
  26. 6.5.1 Windtree Therapeutics Company Information
  27. 6.5.2 Windtree Therapeutics Business Overview
  28. 6.5.3 Windtree Therapeutics Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Windtree Therapeutics Lung Surfactants Product Portfolio
  30. 6.5.5 Windtree Therapeutics Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Lung Surfactants Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
7 North America by Country
  1. 7.1 North America Lung Surfactants Sales by Country
  2. 7.1.1 North America Lung Surfactants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lung Surfactants Sales by Country (2021-2026)
  4. 7.1.3 North America Lung Surfactants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lung Surfactants Market Size by Country
  6. 7.2.1 North America Lung Surfactants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lung Surfactants Market Size by Country (2021-2026)
  8. 7.2.3 North America Lung Surfactants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lung Surfactants Sales by Country
  2. 8.1.1 Europe Lung Surfactants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lung Surfactants Sales by Country (2021-2026)
  4. 8.1.3 Europe Lung Surfactants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lung Surfactants Market Size by Country
  6. 8.2.1 Europe Lung Surfactants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lung Surfactants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lung Surfactants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lung Surfactants Sales by Country
  2. 9.1.1 Asia-Pacific Lung Surfactants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lung Surfactants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lung Surfactants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lung Surfactants Market Size by Country
  6. 9.2.1 Asia-Pacific Lung Surfactants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lung Surfactants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lung Surfactants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lung Surfactants Sales by Country
  2. 10.1.1 South America Lung Surfactants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lung Surfactants Sales by Country (2021-2026)
  4. 10.1.3 South America Lung Surfactants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lung Surfactants Market Size by Country
  6. 10.2.1 South America Lung Surfactants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lung Surfactants Market Size by Country (2021-2026)
  8. 10.2.3 South America Lung Surfactants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lung Surfactants Sales by Country
  2. 11.1.1 Middle East and Africa Lung Surfactants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lung Surfactants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lung Surfactants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lung Surfactants Market Size by Country
  6. 11.2.1 Middle East and Africa Lung Surfactants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lung Surfactants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lung Surfactants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lung Surfactants Value Chain Analysis
  2. 12.1.1 Lung Surfactants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lung Surfactants Production Mode & Process
  7. 12.2 Lung Surfactants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lung Surfactants Distributors
  10. 12.2.3 Lung Surfactants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst